DiaMedica Therapeutics DMAC
NASDAQ DMAC
$9.66 -0.01 (-0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

DiaMedica Therapeutics (DMAC) Return on Equity [ROE] (2018 - 2026)

Updated

DiaMedica Therapeutics (DMAC) recorded Return on Equity [ROE] of -87.74% in Q2 2026, up 9.05 percentage points from -96.79% a year earlier but down 19.81 percentage points from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, DiaMedica Therapeutics reported Return on Equity [ROE] of -67.68%, down 14.41 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for three straight years, though with a five-year change of +5.42 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -53.27% in FY2024 (-6.50 pp), -46.77% in FY2023 (-10.71 pp), -36.06% in FY2022 (+2.75 pp) and -38.81% in FY2021 (+34.29 pp).
  • Quarterly Return on Equity [ROE] has ranged from -96.79% in Q2 2025 to -29.85% in Q4 2021 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] rose in two of the last eight quarters, with an average year-over-year change of -18.83 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 31.19 percentage points in Q2 2022, against a drop of 56.89 percentage points in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -67.93% (Q1 2026), -60.83% (Q4 2025) and -81.04% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 DiaMedica Therapeutics 521.46 Mn 311.42 Mn - -87.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -87.94%
Mar 31, 2026 -68.11%
Dec 31, 2025 -60.90%
Sep 30, 2025 -81.13%
Jun 30, 2025 -96.91%
Mar 31, 2025 -72.36%
Dec 31, 2024 -55.13%
Sep 30, 2024 -42.82%
Jun 30, 2024 -39.90%
Mar 31, 2024 -39.55%
Dec 31, 2023 -36.33%
Sep 30, 2023 -31.15%
Jun 30, 2023 -38.17%
Mar 31, 2023 -52.47%
Dec 31, 2022 -40.88%
Sep 30, 2022 -36.19%
Jun 30, 2022 -34.56%
Mar 31, 2022 -31.79%
Dec 31, 2021 -29.85%
Sep 30, 2021 -43.19%
API Access

DiaMedica Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DMAC&period=max&api_key=YOUR_API_KEY